Página 2 - Melhores Imunoterapia para o cancro da próstata médicos - TOP-40 médicos

O Professor Cicin traz mais de 25 anos de experiência em oncologia, com expertise específica em imunoterapia para o câncer de próstata no İstinye University Liv Hospital Topkapı.

• Especializado em oncologia médica com um fellowship pela Universidade Trakya
• Atualmente atua como Professor de Oncologia Médica na Universidade Trakya
• Vasta experiência em contextos oncológicos tanto clínicos quanto acadêmicos

O Prof. Associado Atakan Topcu é especializado em terapias direcionadas e imunoterapia para o câncer de próstata no Hospital Distrital Medipol Acibadem.

• Publicou mais de 50 artigos científicos em oncologia
• Membro da Sociedade Europeia de Oncologia Médica (ESMO)
• Formação de Fellowship em Oncologia Médica na Universidade Bezmialem Vakıf
• Experiência em oncologia geriátrica e desnutrição relacionada ao câncer

Professor Associado de Oncologia Médica no Hospital Liv da Universidade İstinye Topkapı, especializado em imunoterapia para o câncer de próstata.

• Membro da Sociedade Americana de Oncologia Clínica (ASCO) desde 2018
• Publicou múltiplos artigos revisados por pares sobre os resultados do tratamento do câncer
• Coordenador de Educação para a Subárea de Oncologia Médica no Hospital da Cidade Prof. Dr. Cemil Taşcıoğlu

Assoc. Prof. Ayşe İrem Yasin, M.D., is a medical oncologist who specializes in solid tumors. Her clinical focus includes breast, lung, gastrointestinal, gynecologic, and urologic cancers. She also treats brain and other CNS tumors, soft tissue sarcomas, head and neck cancers, adenocarcinomas, melanoma, Merkel cell carcinoma, and cancers of unknown primary. She practices at Medipol Acıbadem District Hospital (2025–present). She previously worked at Şişli Etfal Training and Research Hospital (2023–2025).

She completed a Medical Oncology fellowship at Bezmialem Vakıf University (2019–2022). This followed an Internal Medicine residency at the same institution (2012–2016). Her international experience includes the Breast Cancer Unit at the University of Piemonte Orientale in Novara (2022). She also trained at Basel University Hospital, Cleveland Clinic, and Harvard Medical School. She holds the ESMO Board Certificate (2022).

Dr. Nir Kleinmann, MD, directs the Endourology and Kidney Stones Unit at Sheba Medical Center. He is an expert in minimally invasive urology and urologic oncology. His focus is the kidney and upper urinary tract. He was named among Israel’s Best Doctors for 2025–2026 by Forbes and ResultMed.

He is a pioneer of kidney‑sparing laser surgery. He uses a dual‑laser system with neodymium and holmium for complex tumors. His expertise includes UTUC, kidney and prostate cancer, kidney stones, and BPH.

His research includes the OLYMPUS trial on chemoablation for UTUC. He has more than 60 publications.

He is an Israeli board‑certified urologist. He is a Fellow of the American Endourology Society and a member of the Israeli Urological Association and the EAU. He completed fellowships in Endourology and Minimally Invasive Surgery at Thomas Jefferson University. He also completed a fellowship in Kidney Cancer Research at McMaster University.

Dr. Yaacov Lawrence, MA, MBBS, MRCP, is Chair of Radiation Oncology at Sheba Medical Center. He has nearly 30 years of experience in precision radiation oncology and neuro-oncology.

He is an expert in advanced radiation therapy and radiosurgery. He performs stereotactic radiosurgery for brain tumors. He leads Sheba’s GI Cancer Program in gastrointestinal oncology. He also provides precision care for lung and prostate cancers. He pioneered celiac plexus radiosurgery for severe pain from pancreatic cancer.

Training and credentials: MA and MBBS (Cambridge and UCLH); MRCP (RCP); Radiation Oncology fellowship (Thomas Jefferson University). Honors include the ASCO Young Investigator Award and Fellow of ASTRO (FASTRO). He has authored over 280 publications. He is Director of the Center for Translational Radiation Oncology and an Associate Professor at Tel Aviv University.

Dr. Osama Abdel Mohimen Mohamed is Head of the Hematology Unit at Shefaa Al Orman Oncology Hospitals. He is also a consultant in medical oncology and hematology at Shefa El Orman Hospital (NGO), Luxor (2019–present).

He diagnoses and treats acute and chronic leukemia, lymphoma, myeloma, myelodysplastic syndromes, and myeloproliferative neoplasms. He also manages complications of solid tumors.

Background: He served at the National Cancer Institute, Cairo University, as a medical oncology resident, then demonstrator and assistant lecturer (2008–2022). Earlier, he was a house officer (2006–2007). He also held specialist roles at Al Salam International, Al Molalmen, and BAHEYA Oncology Center (NGO).

Memberships: ESMO (2008–present). American Society of Bone Marrow Transplantation (2009). ASH (2010).

Dr. Maha Yahia is a medical oncologist and hemato-oncologist. She provides assessment, diagnosis, and treatment planning. Her treatments include chemotherapy, targeted therapy, and immunotherapy. She cares for patients with breast, genitourinary, gynecologic, thoracic, gastrointestinal, and rare cancers.

Education: M.B.B.Ch, Kasr El-Aini, Cairo University (1997–2003). Master in Hemato-oncology, National Cancer Institute, Cairo University (2008). Doctoral Degree in Hemato-oncology, National Cancer Institute, Cairo University (2015).

Experience: Resident in Medical Oncology, Maadi AFMC (2005–2010). Visitor Resident, NCI Cairo (2008–2009). Consultant Assistant, Prof. Hussein Khaled Clinic (2010–2017). Specialist, International Medical Center (2011–2012), Wadi El Nile Hospital (2013–2014), and Maadi AFMC (2011–2018). Head, Clinical Research Support Team, Maadi AFMC (2016–2018). Major (2014–2016) and Lt. Colonel Doctor (2016–2018), Egyptian Armed Forces. Lecturer of Clinical Research, AFCM (2019–2021).

Dr. Emad Shash, M.B.B.Ch, MSc, M.D., is a medical oncologist. He is the Medical Director of the Breast Comprehensive Cancer Hospital at NCI. He leads the Medical Oncology Department and is the Breast Program Director at Shifaa Al Orman Cancer Hospital in Luxor. His clinical focus includes breast, gynecologic, genitourinary, thoracic, gastrointestinal, and rare cancers. He specializes in systemic therapy, including chemotherapy, targeted therapy, and immunotherapy.

He served as coordinating research physician and medical lead at the EORTC from 2011 to 2015. Since 2008, he has contributed to more than 70 international oncology trials as a coordinator, sub-investigator, principal investigator, and sponsor medical monitor. Credentials include M.B.B.Ch (2004), MSc (2010), MD (2015), and the EORTC Certificate of Excellence (2015). He also holds a Diploma in Hospital Quality Management & Patient Safety (JCI/57357, 2017). He is a Fellow of the EIO. He is a member of ESMO (panel voting), ESGO, and ASCO (IAC), and serves on the ECRIN board.

Dr. Mariam Mohammed Hussein Abu Zeid is a clinical oncologist. She treats solid tumors and hematologic cancers. She earned her MBBCh from Ain Shams University in 2007 (Excellent). She completed a Master’s in Clinical Oncology and Nuclear Medicine in 2011 (Very Good). She received a Ph.D. in 2018 and an ESMO Certificate in 2015.

She leads and monitors clinical trials. Her work includes data collection and analysis. She administers chemotherapy and manages treatment toxicities. She also plans care with multidisciplinary teams. Her experience includes Ain Shams University Hospitals (2009–2012), the International Medical Center (2012–2014), and Wadi El Nile Hospital (2015–2019). Her roles covered diagnosis and staging, supportive care, quality improvement, and screening. She educates patients and families about the diagnosis, treatment options, and palliative care.

Especialista em radioterapia – O Dr. Sridhar P.S. traz profunda experiência no tratamento do cancro da próstata no HCG Manavata Cancer Centre.

• Diplomado pelo Conselho Nacional em radioterapia
• Membro da Associação de Radioterapia Oncológica da Índia
• Membro do Grupo de Oncologia de Bangalore
• Especialista em neuro-oncologia e oncologia por hipertermia

Mais de 50.000 cirurgias oncológicas realizadas ao longo de 19 anos – O Dr. Nagarkar é especialista em oncologia cirúrgica com foco na melhoria da qualidade de vida dos pacientes.

• Formado no Tata Memorial Hospital e no Royal College of Surgeons, Edimburgo
• Realizou mais de 200 ensaios clínicos nas fases 1-3
• Especialista em oncologia cirúrgica mamária e torácica
• Professor de DNB Superspecialty Surgical Oncology e Cirurgia de Mama

Apresentou pesquisas sobre câncer de estômago no simpósio da Sociedade Americana de Oncologia Clínica – O Dr. Valame é especialista em terapias alvo para o câncer de próstata.

• DNB em Oncologia Médica pelo Hospital Indraprastha Apollo
• Registrar em Oncologia Médica no Hospital de Câncer Jawaharlal Nehru
• Palestrante na International Winter School of Oncology
• Especialista nas bases moleculares do câncer

Mais de 10.000 cirurgias de grande porte realizadas em 10 anos, especializado em cirurgias oncológicas minimamente invasivas com excelentes resultados.

• Treinamento de fellowship em oncologia cirúrgica no Tata Medical Centre, Kolkata
• Foco especial em cirurgias de câncer gastrointestinal
• Co-investigador principal em múltiplos projetos de pesquisa originais
• Publicado em periódicos nacionais e internacionais

O Dr. Ahmer Arif Shaikh é especialista em oncologia cirúrgica com foco em câncer oral e reabilitação funcional no HCG Manavata Cancer Centre.

• 3 anos de experiência em oncologia cirúrgica
• Experiência em preservação de órgãos e reabilitação funcional
• Proficiente em grandes cirurgias maxilofaciais e de cabeça e pescoço
• Formação de Fellowship em Oncologia Cirúrgica de Cabeça e Pescoço
• Pesquisador ativo com múltiplas publicações

A Dra. Shruti Kate é especialista em imunoterapia para cancros avançados, incluindo cancro da próstata, com formação no Tata Memorial Hospital – um centro oncológico de topo na Índia.

• DM em Oncologia Médica pelo Tata Memorial Hospital
• Especialização em cancros do pulmão, da mama e geniturinários
• Membro da ASCO, ESMO e outras sociedades oncológicas líderes
• Investigação apresentada na Conferência Mundial sobre Cancro do Pulmão

O Dr. Borde realizou mais de 30.000 exames de PET e tratou mais de 1.000 pacientes com câncer de tireoide no HCG Manavata Cancer Centre.

• 12 anos de experiência em medicina nuclear
• Especialista em terapias com radioiodo e Lu-177 RN
• Pesquisas publicadas em periódicos médicos
• Proficiente em exames de PET-CT e cardiologia nuclear